An observational study was undertaken to describe a nosocomial outbreak caused by multiresistant Klebsiella pneumoniae (MRKP). Ten patients in the pediatric intensive care unit (ICU) at a hospital in Madrid were colonized by or infected with MRKP from October 1997 to April 1998. Thirty-two patients with MRKP-negative surveillance cultures who were admitted to the ICU during the outbreak period were selected as control patients. Random amplified polymorphic DNA analysis of MRKP isolates revealed patterns that were indistinguishable from each other. After identification of colonized patients by surveillance cultures and implementation of standard and contact precautions, the outbreak was controlled. An age !12 weeks (odds ratio [OR], 13.1) and previous treatment with third-generation cephalosporins and aminoglycosides (OR, 31.2) were independently associated with MRKP colonization and/or infection. Individual exposure to antibiotics, irrespective of other clinical determinants, is a risk factor for MRKP acquisition. Screening high-risk patients during outbreaks and reducing the use of third-generation cephalosporins and aminoglycosides contribute to the control of these epidemics.
socomial outbreak caused by a K. pneumoniae strain that was resistant to third-generation cephalosporins, gentamicin, and tobramycin, but not to amikacin. Measures implemented for control of the outbreak and independent potential risk factors associated with colonization or infection with this MRKP strain are reported.
Subjects and Methods
Setting. The present study was carried out in the pediatric intensive care unit (ICU) and the cardiosurgical pediatric ward of Ramó n y Cajal Hospital, in Madrid, Spain. The pediatric ICU serves an average of 50 patients (either medical or cardiosurgical) per month. The unit has a 6-bed box (space in the ward set apart by a transparent partition) and an independent and contiguous 5-bed box. The cardiosurgical pediatric ward is endowed with 6 single boxes and 3 double boxes. Ramó n y Cajal Hospital is a university tertiary level medical referral center with 1120 beds (452 medical, 560 surgical, 56 pediatric, and 70 intensive care beds). The center has ∼30,000 admissions per year.
Study design. This case-control study compared the frequency of exposure and the features of case patients with those of control patients in order to identify and quantify potential independent risk factors associated with MRKP colonization/infection.
Patients. In December 1997, the Department of Microbiology and Infectious Diseases at our facility reported the occurrence of a cluster of MRKP isolates from the pediatric ICU. The infection control personnel were immediately engaged in the outbreak investigation. A review of microbiological records disclosed a single previous case on 7 October 1997. In addition to clinical samples, screening samples were obtained prospectively twice a week from all patients admitted to the pediatric ICU or to the pediatric ward, where the children were transferred after a stay in the pediatric ICU. These screening samples were obtained from the rectum, pharynx, and, if possible, bronchoalveolar aspirates and surgical wounds.
A case patient was defined as a patient who was admitted to the pediatric ICU or pediatric ward during the period of 7 October 1997 to 15 April 1998 and then was either clinically infected with [11] or colonized by K. pneumoniae that was resistant to thirdgeneration cephalosporins and aminoglycosides. A control patient was defined as a patient admitted to the pediatric ICU from 19 December 1997 to 15 April 1998 whose screening cultures were all negative for MRKP. A total of 32 patients met these criteria.
Clinical and epidemiological data were prospectively and retrospectively collected from the medical records of all patients admitted to the unit during that period. The sociodemographic variables recorded were age and sex. In addition, the following potential risk factors were also assessed: birth weight, gestational age, admission diagnosis, hospital clinical course, surgical procedures, number of days of hospital stay prior to admission in the pediatric ICU, length of stay in the unit, and invasive procedures (i.e., mechanical ventilation, central and peripheral venous catheterizations, nasogastric or urinary catheterization, parenteral nutrition, and thoracic drainage), as well as duration in days of such procedures. In addition, the length and type of antimicrobial treatment were recorded.
For the study of risk factors, the period from admission to the first positive culture (for case patients) and from admission to discharge from the pediatric ICU (for control patients) was considered.
Microbiological Studies
Screening for the MRKP strain. Clinical and screening samples were plated onto MacConkey agar plates with and without 1 mg/mL of ceftazidime. Plates were incubated at 37ЊC for 48 h. K. pneumoniae isolates were identified with the semiautomatic PASCO system (Difco, Detroit) and conventional biochemical tests.
Susceptibility testing. MICs were determined by agar dilution according to the guidelines of the National Committee for Clinical Laboratory Standards (NCCLS; M7-A4, 1997) [12] and with the semiautomatic PASCO system. In addition, disk diffusion (NCCLS, M2-A6, 1997) [13] was performed to determine the presence of specific aminoglycoside-modifying enzymes, according to the aminoglycoside-resistance patterns [14] .
b-lactamase studies. ESBL production by MRKP isolates was detected by the double-disk-synergy test [15] . b-lactamase crude sonic extracts for analytical isoelectric focusing were obtained by ultrasonication, as described elsewhere [16] , and the isoelectric point (pI) was determined by application of crude sonic extracts to Phast gels (pH gradients of 3-9 and 4.5-6.5) in a PhastSystem apparatus (Pharmacia AB, Uppsala, Sweden). b-lactamases with known pIs were focused in parallel with the MRKP extracts. Gels were stained with nitrocefin (500 mg/mL; Oxoid, Basingstoke, Hampshire, England).
Random amplified polymorphic DNA analysis. MRKP and control isolates were grown overnight in brain-heart infusion agar. Chromosomal DNA extraction was performed with the Quiagen DNA extraction kit (Quiagen, Bonn, Germany). PCR conditions were modified from those of Gori et al [17] . In brief, 1 m of DNA extract was introduced in the PCR mixture (10 mM of Tris-HCl, 50 mM of KCl, 4 mM of primer, 400 mM each of dNTP, and 2.5 U of Ampli-Taq-Gold DNA polymerase [Perkin Elmer, Branchburg, NJ]) in a final volume of 50 mL. The following primers were used: 5 -TCACGATGCA-3 , 5 -GTATTGCCCT-3 , and 5 -ACGTATCTGC-3.
Amplification was performed in a thermal cycler with 1 cycle of 10 min at 94ЊC; 45 cycles of 1 min at 94ЊC, 1 min at 36ЊC, and 1.5 min at 72ЊC; and a final cycle of 5 min at 72ЊC. PCR products were run in 0.8% agarose gel and stained with ethidium bromide. Random amplified polymorphic DNA (RAPD) analysis was performed on 10 K. pneumoniae outbreak isolates (1 isolate from each patient) and 3 third-generation cephalosporin-susceptible K. pneumoniae clinical isolates.
Mating and transformation assays. Conjugation was performed with the JMG 21 Escherichia coli strain (MC 4100, with kanamycin and nalidixic acid as resistance markers). Transconjugants were selected in Mueller-Hinton agar with a 100-mg/Ml concentration of ampicillin and a 100-mg/mL concentration of nalidixic acid. The TG-1 E. coli strain was used as the receptor strain in transformation assays, and the transformants were selected in Mueller-Hinton agar with ampicillin (100 mg/mL).
Statistical analysis. The cumulative incidence of colonization/infection by MRKP during the outbreak, as well as on a monthly basis, was calculated. Data were stored and analyzed by means of the Statistix statistical software package [18] (Analytical Software, St. Paul, MN) and Epi Info [19] (Centers for Disease Control and Prevention, Atlanta, GA). Univariate analysis was carried out for determination of variables significantly associated with colonization/infection with MRKP. Contingency tables were analyzed by two-tailed Mantel-Haenzel x 2 test or by Fisher's exact test. The Mantel-Haenzel test for trend was used when a dose-response association was suspected. Quantitative variable differences between case and control patients were compared by Student's t-test or the Wilcoxon rank-sum test when appropriate.
A multiple-regression logistic model was developed to identify the potential independent factors associated with colonization/infection by MRKP. From a maximum model including all potential risk factors showing a P value !.25 in the univariate analysis, a final model was developed by a backward strategy [20] . Ninety-five percent CIs were calculated for estimators. Two-sided tests were used for all analyses.
was consid-P ! .05 ered to be statistically significant. 
Results

Outbreak description and control measures.
A total of 235 patients were admitted to the pediatric ICU and cardiosurgical pediatric ward over the study period. Ten of the patients were colonized/infected with MRKP. Four patients were infected, and periodic screening of all patients in the pediatric ICU and the ward allowed us to identify 6 colonized patients. Indeed, isolation of all these patients may have helped limit the spread of the MRKP outbreak.
The MRKP outbreak strain was first isolated in cultures of blood and umbilical cord specimens from a 16-day-old neonate on 7 October 1997. This newborn was admitted to the hospital on 24 September 1997. The diagnosis was great-vessels transposition, and he had remained in the cardiosurgical pediatric ward until admission to the pediatric ICU in October, when his general health status worsened. He died on 17 February 1998 of cardiogenic shock. This patient was considered the index case of the outbreak.
The MRKP strain was isolated again, on 13 December 1997, from a sample of bronchoalveolar aspirate from a 7-day-old neonate with faulty pulmonary drainage and interatrial communication. From 19 December 1997 to 23 January 1998, cultures of specimens from 6 additional patients revealed the same MRKP strain. In February 1998, 2 more positive samples were obtained from the rectums of 2 neonates (aged 3 and 8 months).
Four of the 6 treated patients had persistent MRKP colonization evident in rectal samples. All the above patients underwent surgery during hospitalization because of congenital heart abnormalities (table 1) .
Cultures of 27 environmental samples (from water reservoirs, medical devices, and surfaces) and of 17 samples from the hands of health care personnel working in the affected areas were performed, and all of them were negative for MRKP. On 15 April 1998, the outbreak was considered to be extinguished, when the last affected patient was discharged from the hospital. On 28 May 1998, screening was carried out in the hospital areas involved by the outbreak, and 14 patient samples were all negative for MRKP.
The outbreak was controlled by implementation of certain measures: case patients were either isolated in single boxes (whenever possible) or grouped in cohorts, and the standard and contact isolation precautions were strengthened. Health care personnel were reminded to wash their hands carefully before and after contact with patients and to wear disposable gloves and gowns.
In addition, doctors were encouraged to use antibiotics with caution, particularly third-generation cephalosporins and aminoglycosides. Analysis of the rates of use of third-generation cephalosporins and aminoglycosides (gentamicin or tobramycin), measured as the number of patient-days of antibiotic therapy per 100 patient-days, showed a linear decreasing trend during the epidemic period (x 2 test values for trend, 56.8 and 15.3, respectively;
; figure 1 ). This decreasing use of these P ! .001 antibiotics parallels the decrease in incidence of colonization/ infection by MRKP.
Microbiological findings. All selected MRKP isolates, 1 from each patient, had RAPD patterns that were indistinguishable from each other. This pattern was clearly different from that of nonoutbreak control isolates. MRKP isolates were positive in double-disk diffusion tests. Table 2 shows the MICs of anitmicrobials used against the MRKP isolates and the corresponding transconjugants and transformants. All MRKP isolates showed resistance to thirdgeneration cephalosporins and aztreonam and decreased susceptibility to gentamicin (18 mg/mL) and tobramycin (8 mg/mL), but not to amikacin (р4 mg/mL). b-lactam, gentamicin, and tobramycin resistance were cotransferred by both conjugation and transformation. Analytical isoelectric focusing of MRKP isolates revealed 2 b-lactamase bands of 7.6 and 5.9. The latter b-lactamase band was also observed in both the transconjugants and the transformants. A similar aminoglycoside-resistance profile, suggesting the production of AAC(3 )I enzyme, was detected in all the isolates and the corresponding transconjugants and transformants.
Risk-factor assessment. The cumulative rate of MRKP infection/colonization over the outbreak was 4.3% (95% CI, 2.1-7.7), and the highest incidence was observed in December 1997 (cumulative incidence, 15.2%).
The age of colonized/infected patients ranged from 1 day to 5 years (table 1) . Six patients were males and 4 were females. Only 1 patient's birth weight was low, and another was born prematurely. All 10 patients with MRKP infection/colonization underwent surgery because of various congenital abnormalities at some time during hospitalization. The mean hospital stay was 10 weeks (range, 3-21 weeks). The average length of stay in the pediatric ICU was 16.9 days (range, 1-49 days).
The mean age of control patients was 40 weeks (range, 1-124). Five patients (15.6%) had low birth weights and 5 (15.6%) were premature. Twenty-five patients (78%) had undergone surgery at some time during hospitalization because of congenital heart anomalies. The mean hospital stay was 25.4 days (range, 3 days to 10 weeks). The average stay in the pediatric ICU was 11.3 days (range, 2-54 days).
The univariate analysis yielded the following factors associated with MRKP: age !12 weeks, number of days with a central or peripheral venous catheter, number of days with a nasogastric tube, and previous treatment with third-generation cephalosporins and aminoglycosides. The number of antimicrobial agents received was linearly associated with an increased risk of MRKP acquisition ( ; figure 2) . In addition, the P ! .01 univariate analysis showed differences in the numbers of days of mechanical ventilation, but this difference did not reach statistical significance (  ; table 3 ).
The multiple-logistic-regression model showed that an age !12 weeks (OR, 13.1; 95% CI, 1.3-130) and previous treatment with third-generation cephalosporins and aminoglycosides (gentamicin or tobramycin; OR, 31.2; 95% CI, 3.3-298) were factors independently associated with MRKP infection/ colonization.
Discussion
The most remarkable characteristics of the outbreak we report here of K. pneumoniae that was resistant to third-gener- Figure 2 . Association between an increase in risk of acquiring a multiresistant Klebsiella pneumoniae strain and no. of antibiotics received (x 2 test value for trend, 9.701; ). P = .0018 ation cephalosporins and aminoglycosides were the small number of patients involved and the fact that it subsided in a short period of time. These characteristics are in contrast with those of other such nosocomial MRKP outbreaks reported in the literature, which involved a large number of patients and were of longer duration [7, 21, 22] .
MRKP outbreaks most often start in ICUs [7, [23] [24] [25] [26] , presumably because in these areas patients are exposed to a considerable number of potential risk factors for colonization/infection. Factors such as severe clinical status, extreme age, misuse or abuse of antimicrobial agents, performance of many procedures, and high prevalence of invasive procedures may all contribute to a decrease in patients' resistance to exogenous bacteria and to an increase in cross-infection risk. Therefore ICU patients are ideal reservoirs for MRKP. The digestive tract is the most usual colonized site [27, 28] ; indeed, in all cases in our study, cultures of rectal specimens were MRKP-positive.
According to our data, therapy with third-generation cephalosporins and aminoglycosides (gentamicin or tobramycin) is the most important predictor of acquisition of the epidemic strain, after an age of !12 weeks is accounted for. Although previous studies have suggested this association, to our knowledge none of them have demonstrated that individual exposure to third-generation cephalosporins and aminoglycosides is an independent risk factor for MRKP acquisition [4, 7, 8, 29, 30 ].
An age of !12 weeks probably is a surrogate marker for severity of disease. Younger children in this hospital unit tend to have serious underlying illnesses demanding cardiosurgical repair. Another potential explanation could be that they have different ecosystem flora in their digestive tracts, which, in addition to antibiotic exposure, could make them more vulnerable to multiresistant bacteria.
Furthermore, we found an association in the univariate analysis between higher risk of MRKP colonization or infection and the use of both a nasogastric tube and a central or peripheral venous catheter, but these exposures were not independent predictors in the multivariate analysis. On the contrary, risk factors observed by other authors [7, 8] , such as urinary catheterization, intubation, or invasive medical or surgical procedures, were not encountered as relevant risk factors in our study, presumably because of the small size of our outbreak.
The measures we enforced for outbreak control were in keeping with current recommendations reported in the literature [21, 25, 31, 32] . First, we reinforced standard precautions and implemented contact precautions: we isolated case patients in single rooms when possible or in groups, and we strictly adhered to measures to avoid contact with and transmission of infective agents (i.e., wearing gloves when entering the room, changing gloves after contact with infective material, wearing gowns during procedures likely to generate splashes, adequately cleaning and disinfecting environmental surfaces, and not using reusable equipment for the care of another patient until it was cleaned and reprocessed appropriately).
In addition, the restricted use of third-generation cephalosporins and aminoglycosides played an important role in controlling the outbreak in a short time. Furthermore, the periodic screening of all patients in the pediatric ICU and in the ward allowed us to identify 6 colonized patients. Indeed, isolation of these patients may have helped limit spread of the MRKP outbreak. Most case patients were successfully treated with meropenem and amikacin. The pharmacokinetic properties of the drugs precludes significant action on the intestinal carrier state, and 4 of the 6 treated patients had persistent MRKP colonization evident in rectal samples.
A crucial point for the early control of this outbreak was the immediate reporting of cases from the department of microbiology to the infection control team. Thus, fluid communication between the staffs of both departments, as well as col-laboration with the personnel of the pediatric ICU, was essential. It is our belief that such a collaboration is of paramount importance for immediate success in controlling outbreaks.
In summary, on the basis of our findings, we conclude that individual exposure to third-generation cephalosporins and aminoglycosides, irrespective of other clinical determinants, plays a significant role as risk factor for MRKP outbreaks. In addition to standard and contact precautions, periodic screening of high-risk patients during outbreaks and reducing the use of third-generation cephalosporins and aminoglycosides contribute to the prevention and control of these epidemics.
